Intellectual property continues to play a defining role in shaping innovation, competitiveness and long-term value throughout the life sciences sector.
Recent developments from Oncoinvent and the strategic partnership between CellCarta and Biofidelity highlight how companies are leveraging patents and exclusivity agreements to strengthen their market position and accelerate the adoption of novel technologies.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.